Patent ID: 8177778
Filing Date: 2012-05-15
Classification: A61B,A61F,A61K,A61M,A61P

Abstract:
1. A system for applying therapy to an eye, the system comprising: an electrical energy source; an electrical energy conducting element in contact with the electrical energy source, the electrical energy conducting element having a proximal end configured to receive electrical energy generated by the electrical energy source, and a distal end configured to apply electrical energy; a wound healing inhibitor including Mannose 6-phosphate (M6P), the wound healing inhibitor being configured to reduce corneal haze by competing with latent Transforming Growth Factor beta (TGFb) at an Insulin Like Growth Factor II receptor; a wound healing inhibitor delivery element in contact with the wound healing inhibitor; a processor configured to determine Transforming Growth Factor beta (TGFb) activity, a coolant supply; and a coolant delivery element in contact with the coolant supply, the coolant delivery element configured to deliver a pulse of coolant wherein the wound healing inhibitor delivery element is adjusted based on the Transforming Growth Factor beta (TGFb) activity.